Retatrutide is a new treatment in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By boosting these receptors, https://sachinkykd140945.azzablog.com/36476438/tirzepatide-a-promising-new-treatment-for-obesity